Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06722820
PHASE1

Study to Evaluate LPH-5 in Healthy Subjects

Sponsor: Lophora

View on ClinicalTrials.gov

Summary

This study will explore the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of LPH-5.

Official title: Phase I, First-in-man, Randomised, Placebo-controlled, Single Dose Escalation Study to Investigate the Effects of LPH-5 on Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Parameters in Healthy Participants

Key Details

Gender

MALE

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

48

Start Date

2025-04-30

Completion Date

2025-12-31

Last Updated

2024-12-09

Healthy Volunteers

Yes

Interventions

DRUG

LPH-5

LPH-5

DRUG

Placebo

Placebo